Professor Alexander Seifalian

Professor Alexander Seifalian

The London BioScience Innovation Centre, London
Director of nanotechnology & regenerative medicine commercialisation centre

Why we invited Alexander

Alexander Seifalian, professor of nanotechnology and regenerative medicine, has worked at the Royal Free Hospital and University College London for over 26 years. He spent a year at Harvard Medical School looking at the cause of cardiovascular diseases and a year at Johns Hopkins Medical School looking at liver treatment. He has published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research.  During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”.
 

His achievements include development of the world’s first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cell technology.

Where you can see Alexander

27 Sep 2017
Time:  14:30
Main Stage
The next generation of plastics for biomedical application will be based on carbon-based nanomaterials - Professor Alexander M Seifalian, Director & Professor of Nanotechnology & Regenerative Medicine - The London BioScience Innovation Centre

Why you should attend this presentation 

Previously we have developed a nanocomposite material (POSS) inspired by nature by studying butterfly wings, using this material number of organs were developed and implanted in patients including the world’s first synthetic trachea with stem cells. However its lack integration with the surrounding tissue, therefore we moved to carbon based materials. Graphene is 200 times stronger than steel and has superior chemical and  mechanical properties. In addition, it is conductive. Using carbon - based nanomaterials, we developed a new family of plastic for biomedical application. Currently this new generation of the plastic undergoing extensive biocompatibility and toxicology test at preclinical trial.
 

Alexander Seifalian
HEADLINE MEDIA PARTNER

British Plastics & Rubber

OUR PARTNERS

GTMA

Composites in Manufacturing

European Plastic Product Manufacturer

Machinery

Medilink

Med-Tech

Medical Plastic News

Production Engineering Solutions

Engineering Materials

PMMDA

British Plastics Federation

Women in Plastics

Mould Technology

Composities UK

Plastic-Technology

inside comp

Innovation in Text

Proffessional Engineering

Engineering Update

Knowledge Transfer Network

The Worshipful Company of Horners

Plastics Consultancy Network

Society of Plastics Engineers

Arena Trade Group

Taiwan Machine Tools

PlastikCity

packaging Europe

Plastics Information Europe

Prototype today

AMT

Eureka

imeche

Plastics News Europe

Scottish Plastics and Rubber

tecnoedizioni.com

engineer

plastech

RapidNews communications logo